Clinical Utility of Serum Glycodelin as a Novel Marker for Ovarian Cancer
Mohamed Samir Abd-Allah Mahmoud Hegab;
Abstract
Summary
Ovarian cancer is a malignancy that arises from various different cells within the ovaries. It is the fifth leading cause of death from cancer. It has been called "Silent killer" because it frequently causes non specific symptoms, which contribute
Ovarian cancer is a malignancy that arises from various different cells within the ovaries. It is the fifth leading cause of death from cancer. It has been called "Silent killer" because it frequently causes non specific symptoms, which contribute
Other data
| Title | Clinical Utility of Serum Glycodelin as a Novel Marker for Ovarian Cancer | Other Titles | الفائدة الإكلينيكية للجليكودلين فى المصل كدلاله حديثة لسرطان المبيض | Authors | Mohamed Samir Abd-Allah Mahmoud Hegab | Keywords | Clinical Utility of Serum Glycodelin as a Novel Marker for Ovarian Cancer | Issue Date | 2013 | Description | Summary Ovarian cancer is a malignancy that arises from various different cells within the ovaries. It is the fifth leading cause of death from cancer. It has been called "Silent killer" because it frequently causes non specific symptoms, which contribute |
Attached Files
| File | Size | Format | |
|---|---|---|---|
| 117006Mohamed Hegab 3 -Thesis 27 4 .pdf | 670.29 kB | Adobe PDF | View/Open |
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.